Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of stat3, hbx, stat3-hbx targeting CRISPR/Cas carrier in the preparation of HBV-related liver cancer drugs

A carrier and targeting technology, applied in the field of genetic engineering, can solve problems such as unsolved problems, and achieve the effect of promoting cell apoptosis, reducing expression, and promoting cell apoptosis

Active Publication Date: 2021-08-10
SHANDONG UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is currently no high-efficiency vector for the Stat3 target, and a gene knockout product that can simultaneously knock out the two targets of Stat3-HBx

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of stat3, hbx, stat3-hbx targeting CRISPR/Cas carrier in the preparation of HBV-related liver cancer drugs
  • Application of stat3, hbx, stat3-hbx targeting CRISPR/Cas carrier in the preparation of HBV-related liver cancer drugs
  • Application of stat3, hbx, stat3-hbx targeting CRISPR/Cas carrier in the preparation of HBV-related liver cancer drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0094] Example 1: Construction of single-function silencing vectors targeting Stat3 and HBx respectively

[0095] Select the PX333 vector, digest it with BsaⅠ, and recover the linear fragment through agarose gel. According to the design strategy of CRISPR / Cas9 sgRNA, design 3 sgRNAs for the second and eighth exons of Stat3; for the gene sequence of HBx Design 2 sgRNAs (Table 1). The sgRNA fragments were annealed, ligated with the recovered fragments of the PX333 vector by T4 ligase, transformed into competent cells, and single clones were selected for sequencing. Sequencing results showed that 3 kinds of monofunctional plasmids targeting Stat3 and 2 kinds of targeting HBx were successfully constructed.

[0096] Table 1: sgRNA information

[0097]

[0098]

Embodiment 2

[0099] Example 2: Screening of a single-function silencing vector targeting Stat3

[0100] (1) Both Stat3-sgRNA1 and Stat3-sgRNA2 can reduce the expression of Stat3 protein

[0101] Experimental method: HepG2.2.15 cells use liposome Lipo6000 as a transfection reagent, set ctrl control, lipo6000 control (transfection reagent only), PX333 (vector control), and three plasmid vectors constructed to silence stat3, transfect After 48 hours of staining, the protein was extracted and detected by Western Blot.

[0102] Result: as attached figure 2 As shown, the results show that targeting both Stat3-sgRNA1 and sgRNA2 sequences can reduce the expression of Stat3 protein.

[0103] (2) Stat3-sgRNA1 and Stat3-sgRNA2 inhibit the proliferation of HepG2.2.15 cells

[0104] Methods: MTT and living cell monitor were used to study the proliferation of HepG2.2.15 cells after transfection of Stat3 plasmid.

[0105] Results: MTT results showed that targeting the Stat3-sgRNA1 sequence could inhib...

Embodiment 3

[0131] Example 3: Screening of HBx-targeting monofunctional silencing vectors

[0132] HBx-sgRNA2 inhibits the expression of HBx protein

[0133] Method: HepG2.2.15 cells use liposome Lipo6000 as transfection reagent, set ctrl control, lipo6000 control (transfection reagent only), PX333 (vector control), and two plasmid vectors constructed to silence HBx, and transfect After 48 hours, the protein was extracted, and the expression of HBx, p-Stat3, and Stat3 proteins were detected by Western Blot. The results are shown in the attached Figure 8 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a Stat3-targeting CRISPR / Cas carrier, a Stat3-HBx dual-targeting CRISPR / Cas carrier and two repeat-targeting HBx-targeting CRISPR / Cas carriers, in particular to a Stat3-targeting single function Plasmids, a Stat3-HBx dual-targeting CRISPR / Cas vector, two repeating HBx-targeting CRISPR / Cas vectors, and methods for constructing the above-mentioned vectors. The inventors have proved through experiments that the vector constructed in this invention has a specific targeted therapeutic effect on HBV-related liver cancer cells. The present invention correspondingly protects the above-mentioned silencing gene vector, the construction method of the vector, the dual silencing strategy of the vector for Stat3 and HBx, and The application of the carrier in the preparation of HBV chronic infection and anti-liver cancer related drugs.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and specifically relates to the application of Stat3 and HBx target gene CRISPR / Cas silencing vectors in inhibiting HBV chronic infection and treating HBV-related liver cancer. Background technique [0002] Hepatocellular carcinoma is one of the five most common cancers in the world and ranks the third cause of cancer death. In clinical treatment, the five-year survival rate of liver cancer patients is only about 10%. According to the latest 2015 Chinese cancer statistics, liver cancer is the most common cancer diagnosed before the age of 60, and accounts for the first cancer death rate in men, followed by lung cancer and stomach cancer. HBV infection has been considered as an important risk factor for HCC. In many tumors such as liver cancer, there is abnormal expression and persistent activation of signal transducers and activators of transcription 3 (STAT3), and its target genes i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/113C12N15/85C12N15/90A61K31/713A61P35/00A61P31/20
CPCA61K31/713A61P31/20A61P35/00C07K14/005C07K14/4702C12N15/113C12N15/85C12N15/907C12N2310/10C12N2730/10122C12N2310/20
Inventor 张建郭全娟韩秋菊
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com